Credit Suisse Group Reiterates Outperform Rating for Smiths Group (SMIN)
Smiths Group (LON:SMIN)‘s stock had its “outperform” rating reaffirmed by investment analysts at Credit Suisse Group in a report released on Friday. They presently have a GBX 1,730 ($23.28) price target on the stock. Credit Suisse Group’s target price would indicate a potential upside of 17.37% from the stock’s current price.
A number of other brokerages have also commented on SMIN. J P Morgan Chase & Co reaffirmed an “overweight” rating on shares of Smiths Group in a report on Thursday. Numis Securities reaffirmed a “hold” rating and issued a GBX 1,600 ($21.53) price objective on shares of Smiths Group in a report on Tuesday, December 5th. reaffirmed a “buy” rating and issued a GBX 1,900 ($25.57) price objective on shares of Smiths Group in a report on Friday, September 29th. Goldman Sachs Group reaffirmed a “buy” rating and issued a GBX 1,850 ($24.90) price objective on shares of Smiths Group in a report on Friday, September 22nd. Finally, Deutsche Bank reaffirmed a “buy” rating and issued a GBX 1,750 ($23.55) price objective on shares of Smiths Group in a report on Monday, December 4th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of GBX 1,754.38 ($23.61).
Shares of Smiths Group (SMIN) traded up GBX 14 ($0.19) during trading on Friday, hitting GBX 1,474 ($19.84). The stock had a trading volume of 318,992 shares, compared to its average volume of 1,050,000. Smiths Group has a one year low of GBX 1,396 ($18.79) and a one year high of GBX 1,685 ($22.68).
In other news, insider George Buckley bought 1,111 shares of the company’s stock in a transaction on Wednesday, November 1st. The stock was purchased at an average cost of GBX 1,577 ($21.22) per share, for a total transaction of £17,520.47 ($23,580.71).
TRADEMARK VIOLATION NOTICE: This report was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/12/11/credit-suisse-group-reiterates-outperform-rating-for-smiths-group-smin.html.
Smiths Group Company Profile
Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.
Receive News & Ratings for Smiths Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group plc and related companies with MarketBeat.com's FREE daily email newsletter.